References
- Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115-125 https://doi.org/10.1055/s-2004-828889
- Levy AD, Murakata LA, Rohrmann CA Jr. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics 2001;21:295-314 https://doi.org/10.1148/radiographics.21.2.g01mr16295
- Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 2014;6:99-109 https://doi.org/10.2147/CLEP.S37357
- Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005;366:1303-1314 https://doi.org/10.1016/S0140-6736(05)67530-7
- Shin YM. Surveillance method and imaging characteristics of recurrent biliary cancer after surgical resection. Korean J Hepatobiliary Pancreat Surg 2014;18:73-76 https://doi.org/10.14701/kjhbps.2014.18.3.73
- Li T, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, et al. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Liver Int 2014;34:953-960 https://doi.org/10.1111/liv.12364
- Chan KM, Tsai CY, Yeh CN, Yeh TS, Lee WC, Jan YY, et al. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence. BMC Gastroenterol 2018;18:180
- Benson AB 3rd, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, et al. NCCN guidelines insights: hepatobiliary cancers, version 1.2017. J Natl Compr Canc Netw 2017;15:563-573 https://doi.org/10.6004/jnccn.2017.0059
- Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014;60:1268-1289 https://doi.org/10.1016/j.jhep.2014.01.021
- Cai Y, Cheng N, Ye H, Li F, Song P, Tang W. The current management of cholangiocarcinoma: a comparison of current guidelines. Biosci Trends 2016;10:92-102 https://doi.org/10.5582/bst.2016.01048
- Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, et al. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001;33:1029-1035 https://doi.org/10.1053/jhep.2001.23912
- Park TG, Yu YD, Park BJ, Cheon GJ, Oh SY, Kim DS, et al. Implication of lymph node metastasis detected on 18F-FDG PET/CT for surgical planning in patients with peripheral intrahepatic cholangiocarcinoma. Clin Nucl Med 2014;39:1-7 https://doi.org/10.1097/RLU.0b013e3182867b99
- Jiang L, Tan H, Panje CM, Yu H, Xiu Y, Shi H. Role of 18F-FDG PET/CT imaging in intrahepatic cholangiocarcinoma. Clin Nucl Med 2016;41:1-7 https://doi.org/10.1097/RLU.0000000000000998
- Joo I, Lee JM, Yoon JH. Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges. Radiology 2018;288:7-13 https://doi.org/10.1148/radiol.2018171187
- Lee DH, Lee JM, Hur BY, Joo I, Yi NJ, Suh KS, et al. Colorectal cancer liver metastases: diagnostic performance and prognostic value of PET/MR imaging. Radiology 2016;280:782-792 https://doi.org/10.1148/radiol.2016151975
- Joo I, Lee JM, Lee DH, Lee ES, Paeng JC, Lee SJ, et al. Preoperative assessment of pancreatic cancer with FDG PET/MR imaging versus FDG PET/CT plus contrast-enhanced multidetector CT: a prospective preliminary study. Radiology 2016;282:149-159 https://doi.org/10.1148/radiol.2016152798
- Buchbender C, Heusner TA, Lauenstein TC, Bockisch A, Antoch G. Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis. J Nucl Med 2012;53:928-938 https://doi.org/10.2967/jnumed.112.105338
- Oldan JD, Shah SN, Rose TL. Applications of PET/MR imaging in urogynecologic and genitourinary cancers. Magn Reson Imaging Clin N Am 2017;25:335-350 https://doi.org/10.1016/j.mric.2016.12.004
- Lee Y, Yoo IR, Boo SH, Kim H, Park HL, O JH. The role of F-18 FDG PET/CT in intrahepatic cholangiocarcinoma. Nucl Med Mol Imaging 2017;51:69-78 https://doi.org/10.1007/s13139-016-0440-y
- Choi KS, Lee JM, Joo I, Han JK, Choi BI. Evaluation of perihilar biliary strictures: does DWI provide additional value to conventional MRI? AJR Am J Roentgenol 2015;205:789-796 https://doi.org/10.2214/AJR.14.14089
- Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-17; discussion 517-519 https://doi.org/10.1097/00000658-200110000-00010
- Lee HY, Kim SH, Lee JM, Kim SW, Jang JY, Han JK, et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 2006;239:113-121 https://doi.org/10.1148/radiol.2383050419
- Park HS, Lee JM, Choi JY, Lee MW, Kim HJ, Han JK, et al. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am J Roentgenol 2008;190:396-405 https://doi.org/10.2214/AJR.07.2310
- Amin MB, Edge SB. AJCC cancer staging manual, 8th ed. New York: Springer, 2017
- Gaertner FC, Furst S, Schwaiger M. PET/MR: a paradigm shift. Cancer Imaging 2013;13:36-52 https://doi.org/10.1102/1470-7330.2013.0005
- Catana C, Guimaraes AR, Rosen BR. PET and MR imaging: the odd couple or a match made in heaven? J Nucl Med 2013;54:815-824 https://doi.org/10.2967/jnumed.112.112771
- Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010;257:674-684 https://doi.org/10.1148/radiol.10100729
- Lee JM, Zech CJ, Bolondi L, Jonas E, Kim MJ, Matsui O, et al. Consensus report of the 4th international forum for gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging. Korean J Radiol 2011;12:403-415 https://doi.org/10.3348/kjr.2011.12.4.403
- Roth CG, Marzio DH, Guglielmo FF. Contributions of magnetic resonance imaging to gastroenterological practice: MRIs for GIs. Dig Dis Sci 2018;63:1102-1122 https://doi.org/10.1007/s10620-018-4991-x
- Yoo HJ, Lee JS, Lee JM. Integrated whole body MR/PET: where are we? Korean J Radiol 2015;16:32-49 https://doi.org/10.3348/kjr.2015.16.1.32
- Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology 2003;227:764-770 https://doi.org/10.1148/radiol.2281020423
- Taira AV, Herfkens RJ, Gambhir SS, Quon A. Detection of bone metastases: assessment of integrated FDG PET/CT imaging. Radiology 2007;243:204-211 https://doi.org/10.1148/radiol.2431052104
- Martin O, Schaarschmidt BM, Kirchner J, Suntharalingam S, Grueneisen J, Demircioglu A, et al. PET/MRI versus PET/CT for whole-body staging: results from a single-center observational study on 1,003 sequential examinations. J Nucl Med 2020;61:1131-1136 https://doi.org/10.2967/jnumed.119.233940
- Ryoo I, Lee JM, Chung YE, Park HS, Kim SH, Han JK, et al. Gadobutrol-enhanced, three-dimensional, dynamic MR imaging with MR cholangiography for the preoperative evaluation of bile duct cancer. Invest Radiol 2010;45:217-224 https://doi.org/10.1097/RLI.0b013e3181d2eeb1
- Li J, Kuehl H, Grabellus F, Muller SP, Radunz S, Antoch G, et al. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol 2008;98:438-443 https://doi.org/10.1002/jso.21136
- Low RN. Diffusion-weighted MR imaging for whole body metastatic disease and lymphadenopathy. Magn Reson Imaging Clin N Am 2009;17:245-261 https://doi.org/10.1016/j.mric.2009.01.006
- Patel CM, Sahdev A, Reznek RH. CT, MRI and PET imaging in peritoneal malignancy. Cancer Imaging 2011;11:123-139 https://doi.org/10.1102/1470-7330.2011.0016
- Lin E, Alessio A. What are the basic concepts of temporal, contrast, and spatial resolution in cardiac CT? J Cardiovasc Comput Tomogr 2009;3:403-408 https://doi.org/10.1016/j.jcct.2009.07.003
- Huang SY, Seethamraju RT, Patel P, Hahn PF, Kirsch JE, Guimaraes AR. Body MR imaging: artifacts, k-space, and aolutions-erratum. Radiographics 2015;35:1624
- Dutta J, Huang C, Li Q, El Fakhri G. Pulmonary imaging using respiratory motion compensated simultaneous PET/MR. Med Phys 2015;42:4227-4240 https://doi.org/10.1118/1.4921616
- Fuin N, Catalano OA, Scipioni M, Canjels LPW, Izquierdo-Garcia D, Pedemonte S, et al. Concurrent respiratory motion correction of abdominal PET and dynamic contrast-enhanced-MRI using a compressed sensing approach. J Nucl Med 2018;59:1474-1479 https://doi.org/10.2967/jnumed.117.203943